Revolution Medicines (RVMD) Short Interest Ratio & Short Volume → Wall Street legend who predicted 2021 tech crash issues new warning (From Chaikin Analytics) (Ad) Free RVMD Stock Alerts $39.39 +2.01 (+5.38%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Revolution Medicines Short Interest DataCurrent Short Volume12,530,000 sharesPrevious Short Volume12,490,000 sharesChange Vs. Previous Month+0.32%Dollar Volume Sold Short$467.12 millionShort Interest Ratio / Days to Cover8.5Last Record DateApril 30, 2024Outstanding Shares164,990,000 sharesPercentage of Shares Shorted7.59%Today's Trading Volume1,343,368 sharesAverage Trading Volume1,344,505 sharesToday's Volume Vs. Average100% Short Selling Revolution Medicines ? Sign up to receive the latest short interest report for Revolution Medicines and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRVMD Short Interest Over TimeRVMD Days to Cover Over TimeRVMD Percentage of Float Shorted Over Time Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Revolution Medicines Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,530,000 shares $467.12 million +0.3%N/A8.5 $37.28 4/15/202412,490,000 shares $443.89 million +4.1%N/A8.7 $35.54 3/31/202412,000,000 shares $386.76 million -26.8%N/A8.9 $32.23 3/15/202416,400,000 shares $522.01 million -4.4%N/A11.5 $31.83 2/29/202417,150,000 shares $505.58 million +1.1%N/A12.2 $29.48 2/15/202416,960,000 shares $499.98 million +0.1%N/A12.8 $29.48 Get the Latest News and Ratings for RVMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter. 1/31/202416,950,000 shares $470.36 million +6.7%N/A11.9 $27.75 1/15/202415,880,000 shares $452.58 million -1.9%N/A7.8 $28.50 12/31/202316,190,000 shares $464.33 million +9.0%N/A6.5 $28.68 12/15/202314,850,000 shares $395.46 million +4.4%N/A5.7 $26.63 11/30/202314,220,000 shares $331.75 million -12.5%N/A5.7 $23.33 11/15/202316,250,000 shares $346.78 million +14.1%N/A6.7 $21.34 10/31/202314,240,000 shares $281.95 million +31.0%N/A6.1 $19.80 10/15/202310,870,000 shares $325.12 million -0.4%N/A5.1 $29.91 9/30/202310,910,000 shares $301.99 million -16.9%N/A8.6 $27.68 9/15/202313,130,000 shares $417.01 million +1.0%N/A12.4 $31.76 8/31/202313,000,000 shares $441.61 million +8.5%N/A12.5 $33.97 8/15/202311,980,000 shares $367.79 million +8.1%N/A11.3 $30.70 7/31/202311,080,000 shares $290.85 million -5.7%N/A10.6 $26.25 7/15/202311,750,000 shares $313.26 million -0.3%N/A13.3 $26.66 6/30/202311,780,000 shares $315.12 million +7.3%N/A12.5 $26.75 6/15/202310,980,000 shares $276.04 million +5.9%N/A11 $25.14 5/31/202310,370,000 shares $258.52 million +9.9%N/A10.4 $24.93 5/15/20239,440,000 shares $250.54 million -1.9%N/A7.7 $26.54 4/30/20239,620,000 shares $225.97 million -5.7%N/A7.8 $23.49 4/15/202310,200,000 shares $225.83 million -6.0%N/A8.2 $22.14 3/31/202310,850,000 shares $235.01 million +12.7%N/A8.4 $21.66 3/15/20239,630,000 shares $221.30 million +31.6%N/A7.8 $22.98 2/28/20237,320,000 shares $195.88 million -2.8%N/A5.9 $26.76 2/15/20237,530,000 shares $192.32 million +5.0%10.8%7.6 $25.54 1/31/20237,170,000 shares $191.73 million -10.7%10.5%7.3 $26.74 1/15/20238,030,000 shares $241.62 million -1.2%11.8%8.5 $30.09 12/30/20228,130,000 shares $193.66 million -6.2%11.9%8.6 $23.82 12/15/20228,670,000 shares $208.17 million -4.1%12.7%9.4 $24.01 11/30/20229,040,000 shares $213.25 million -6.9%13.3%9.8 $23.59 11/15/20229,710,000 shares $209.83 million -1.8%14.3%11.8 $21.61 10/31/20229,890,000 shares $200.37 million +1.0%14.6%12.1 $20.26 10/15/20229,790,000 shares $180.23 million -13.6%14.8%11.1 $18.41 9/30/202211,330,000 shares $223.43 million +13.1%17.1%11.8 $19.72 9/15/202210,020,000 shares $207.21 million +1.5%15.2%10.6 $20.68This Wall Street stock prediction just went viral (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch just the first 5 minutes of his new prediction RVMD Short Interest - Frequently Asked Questions What is Revolution Medicines' current short interest? Short interest is the volume of Revolution Medicines shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 12,530,000 shares of RVMD short. Learn More on Revolution Medicines' current short interest. What is a good short interest ratio for Revolution Medicines? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RVMD shares currently have a short interest ratio of 8.0. Learn More on Revolution Medicines's short interest ratio. Which institutional investors are shorting Revolution Medicines? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Revolution Medicines: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Revolution Medicines' short interest increasing or decreasing? Revolution Medicines saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 12,530,000 shares, an increase of 0.3% from the previous total of 12,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Revolution Medicines' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Revolution Medicines: Exelixis, Inc. (3.35%), ImmunityBio, Inc. (40.08%), Halozyme Therapeutics, Inc. (6.69%), Vaxcyte, Inc. (7.75%), CRISPR Therapeutics AG (17.18%), Krystal Biotech, Inc. (9.07%), Immunovant, Inc. (14.80%), Mirati Therapeutics, Inc. (6.26%), SpringWorks Therapeutics, Inc. (13.51%), Iovance Biotherapeutics, Inc. (22.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Revolution Medicines stock? Short selling RVMD is an investing strategy that aims to generate trading profit from Revolution Medicines as its price is falling. RVMD shares are trading up $2.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Revolution Medicines? A short squeeze for Revolution Medicines occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RVMD, which in turn drives the price of the stock up even further. How often is Revolution Medicines' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RVMD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: EXEL Short Squeeze IBRX Short Squeeze HALO Short Squeeze PCVX Short Squeeze CRSP Short Squeeze KRYS Short Squeeze IMVT Short Squeeze MRTX Short Squeeze SWTX Short Squeeze IOVA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RVMD) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss Ratings